{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:09:57Z","timestamp":1770365397652,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008235","name":"School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-025-02616-y","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:56:59Z","timestamp":1770310619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spinal fluid antibody profile against bacteria demonstrates intrathecal antibody production in demyelinating diseases"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7096-6879","authenticated-orcid":false,"given":"Emily E.","family":"Polidoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Stosiek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon D.","family":"Laman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-7723","authenticated-orcid":false,"given":"John D.","family":"Kriesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"2616_CR1","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.3390\/v6072571","volume":"6","author":"C Lempp","year":"2014","unstructured":"Lempp C, Spitzbarth I, Puff C, Cana A, Kegler K, Techangamsuwan S, Baumg\u00e4rtner W, Seehusen F (2014) New aspects of the pathogenesis of canine distemper leukoencephalitis. Viruses 6:2571\u20132601","journal-title":"Viruses"},{"key":"2616_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000937","volume":"6","author":"MP Hosking","year":"2010","unstructured":"Hosking MP, Lane TE (2010) The role of chemokines during viral infection of the CNS. PLoS Pathog 6:e1000937","journal-title":"PLoS Pathog"},{"key":"2616_CR3","doi-asserted-by":"crossref","unstructured":"Kennedy PGE, George W, Yu X (2024) The elusive nature of the oligoclonal bands in multiple sclerosis. J Neurol 271:116\u2013124","DOI":"10.1007\/s00415-023-12081-7"},{"key":"2616_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102377","volume":"45","author":"M Palao","year":"2020","unstructured":"Palao M, Fern\u00e1ndez-D\u00edaz E, Gracia-Gil J, Romero-S\u00e1nchez CM, D\u00edaz-Maroto I, Segura T (2020) Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord 45:102377","journal-title":"Mult Scler Relat Disord"},{"key":"2616_CR5","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00701-020-04374-x","volume":"162","author":"L Zanin","year":"2020","unstructured":"Zanin L, Saraceno G, Panciani PP, Renisi G, Signorini L, Migliorati K, Fontanella MM (2020) SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 162:1491\u20131494","journal-title":"Acta Neurochir (Wien)"},{"key":"2616_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375:296\u2013301","journal-title":"Science"},{"key":"2616_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.01.23288943","author":"CR Zamecnik","year":"2023","unstructured":"Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Tubati A, Gomez R, Fouassier C et al (2023) A predictive autoantibody signature in multiple sclerosis. medRxiv. https:\/\/doi.org\/10.1101\/2023.05.01.23288943","journal-title":"medRxiv"},{"key":"2616_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41582-022-00700-2","volume":"18","author":"R H\u00f6ftberger","year":"2022","unstructured":"H\u00f6ftberger R, Lassmann H, Berger T, Reindl M (2022) Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept. Nat Rev Neurol 18:681\u2013688","journal-title":"Nat Rev Neurol"},{"key":"2616_CR9","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526\u20131533","journal-title":"N Engl J Med"},{"key":"2616_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00248","volume":"11","author":"M Primavera","year":"2020","unstructured":"Primavera M, Giannini C, Chiarelli F (2020) Prediction and prevention of type 1 diabetes. Front Endocrinol (Lausanne) 11:248","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2616_CR11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s10067-020-04927-6","volume":"39","author":"D Alpizar-Rodriguez","year":"2020","unstructured":"Alpizar-Rodriguez D, Finckh A (2020) Is the prevention of rheumatoid arthritis possible? Clin Rheumatol 39:1383\u20131389","journal-title":"Clin Rheumatol"},{"key":"2616_CR12","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00109-021-02085-z","volume":"99","author":"E Eckman","year":"2021","unstructured":"Eckman E, Laman JD, Fischer KF, Lopansri B, Martins TB, Hill HR, Kriesel JD (2021) Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria. J Mol Med (Berl) 99:1399\u20131411","journal-title":"J Mol Med (Berl)"},{"key":"2616_CR13","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"2616_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1590\/0004-282x20160066","volume":"74","author":"H Reiber","year":"2016","unstructured":"Reiber H (2016) Knowledge-base for interpretation of cerebrospinal fluid data patterns. Essentials in neurology and psychiatry. Arq Neuropsiquiatr 74:501\u2013512","journal-title":"Arq Neuropsiquiatr"},{"key":"2616_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","volume":"122","author":"H Reiber","year":"1994","unstructured":"Reiber H (1994) Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122:189\u2013203","journal-title":"J Neurol Sci"},{"key":"2616_CR16","first-page":"26","volume":"12","author":"AJ Dorta-Contreras","year":"2019","unstructured":"Dorta-Contreras AJ (2019) Reibergrams. Useful tools for neuroimmunological studies. Physiol Mini Rev 12:26\u201339","journal-title":"Physiol Mini Rev"},{"key":"2616_CR17","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41598-018-38198-8","volume":"9","author":"JD Kriesel","year":"2019","unstructured":"Kriesel JD, Bhetariya P, Wang ZM, Renner D, Palmer C, Fischer KF (2019) Spectrum of microbial sequences and a bacterial cell wall antigen in primary demyelination brain specimens obtained from living patients. Sci Rep 9:1387","journal-title":"Sci Rep"},{"key":"2616_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cmi.2021.03.015","volume":"27","author":"MC Shamier","year":"2021","unstructured":"Shamier MC, Bogers S, Yusuf E, van Splunter M, Ten Berge J, Titulaer M, van Kampen JJA, GeurtsvanKessel CH (2021) The role of antibody indexes in clinical virology. Clin Microbiol Infect 27:1207\u20131211","journal-title":"Clin Microbiol Infect"},{"key":"2616_CR19","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001062","author":"P Schwenkenbecher","year":"2021","unstructured":"Schwenkenbecher P, Skripuletz T, Lange P, D\u00fcrr M, Konen FF, M\u00f6hn N, Ringelstein M, Menge T, Friese MA, Melzer N et al (2021) Intrathecal antibody production against Epstein-Barr, herpes simplex, and other neurotropic viruses in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001062","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2616_CR20","unstructured":"Lowry R (2021) VassarStats: website for statistical computation. http:\/\/www.vassarstats.net\/. Accessed 1 May 2025"},{"key":"2616_CR21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","volume":"20","author":"MJ de Hoon","year":"2004","unstructured":"de Hoon MJ, Imoto S, Nolan J, Miyano S (2004) Open source clustering software. Bioinformatics 20:1453\u20131454","journal-title":"Bioinformatics"},{"key":"2616_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000517","volume":"6","author":"I Katz Sand","year":"2019","unstructured":"Katz Sand I, Zhu Y, Ntranos A, Clemente JC, Cekanaviciute E, Brandstadter R, Crabtree-Hartman E, Singh S, Bencosme Y, Debelius J et al (2019) Disease-modifying therapies alter gut microbial composition in MS. Neurol Neuroimmunol Neuroinflamm 6:e517","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2616_CR23","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1128\/JCM.01900-07","volume":"46","author":"A Fekkar","year":"2008","unstructured":"Fekkar A, Bodaghi B, Touafek F, Le Hoang P, Mazier D, Paris L (2008) Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol 46:1965\u20131967","journal-title":"J Clin Microbiol"},{"key":"2616_CR24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1212\/WNL.39.6.753","volume":"39","author":"JJ Halperin","year":"1989","unstructured":"Halperin JJ, Luft BJ, Anand AK, Roque CT, Alvarez O, Volkman DJ, Dattwyler RJ (1989) Lyme neuroborreliosis: central nervous system manifestations. Neurology 39:753\u2013759","journal-title":"Neurology"},{"key":"2616_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01406-18","volume":"57","author":"ES Theel","year":"2019","unstructured":"Theel ES, Aguero-Rosenfeld ME, Pritt B, Adem PV, Wormser GP (2019) Limitations and confusing aspects of diagnostic testing for neurologic lyme disease in the United States. J Clin Microbiol 57:e01406-e01418","journal-title":"J Clin Microbiol"},{"key":"2616_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","volume":"8","author":"D Gilden","year":"2009","unstructured":"Gilden D, Cohrs RJ, Mahalingam R, Nagel MA (2009) Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 8:731\u2013740","journal-title":"Lancet Neurol"},{"key":"2616_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000688","volume":"7","author":"A Vallino","year":"2020","unstructured":"Vallino A, Dos Santos A, Math\u00e9 CV, Garcia A, Morille J, Dugast E, Shah SP, H\u00e9ry-Arnaud G, Guilloux CA, Gleeson PJ et al (2020) Gut bacteria Akkermansia elicit a specific IgG response in CSF of patients with MS. Neurol Neuroimmunol Neuroinflamm 7:e688","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2616_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc7191","volume":"5","author":"AK Pr\u00f6bstel","year":"2020","unstructured":"Pr\u00f6bstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A et al (2020) Gut microbiota-specific IgA(+) B cells traffic to the CNS in active multiple sclerosis. Sci Immunol 5:eabc7191","journal-title":"Sci Immunol"},{"key":"2616_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577700","volume":"360","author":"M Farshbafnadi","year":"2021","unstructured":"Farshbafnadi M, Agah E, Rezaei N (2021) The second brain: the connection between gut microbiota composition and multiple sclerosis. J Neuroimmunol 360:577700","journal-title":"J Neuroimmunol"},{"key":"2616_CR30","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","volume":"185","author":"iMSMS Consortium","year":"2022","unstructured":"iMSMS Consortium (2022) Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course. Cell 185:3467-3486.e16","journal-title":"Cell"},{"key":"2616_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14165771","volume":"14","author":"C Cruciani","year":"2025","unstructured":"Cruciani C, Math\u00e9 C, Puthenparampil M, Tomas-Ojer P, Docampo MJ, Opfer R, Jelcic I, Nicot AB, Laplaud DA, Martin R et al (2025) Intrathecal anti-Akkermansia muciniphila IgG responses in multiple sclerosis patients linked to CSF immune cells and disease activity. J Clin Med 14:5771","journal-title":"J Clin Med"},{"key":"2616_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214222","volume":"23","author":"J Finsterer","year":"2022","unstructured":"Finsterer J (2022) Triggers of Guillain-Barr\u00e9 syndrome: Campylobacter jejuni predominates. Int J Mol Sci 23:14222","journal-title":"Int J Mol Sci"},{"key":"2616_CR33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S (2021) Guillain-Barr\u00e9 syndrome. Lancet 397:1214\u20131228","journal-title":"Lancet"},{"key":"2616_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA (2016) Guillain-Barr\u00e9 syndrome. Lancet 388:717\u2013727","journal-title":"Lancet"},{"key":"2616_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228883","volume":"15","author":"M Graner","year":"2020","unstructured":"Graner M, Pointon T, Manton S, Green M, Dennison K, Davis M, Braiotta G, Craft J, Edwards T, Polonsky B et al (2020) Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides. PLoS One 15:e0228883","journal-title":"PLoS One"},{"key":"2616_CR36","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.1073\/pnas.1522730113","volume":"113","author":"SM Br\u00e4ndle","year":"2016","unstructured":"Br\u00e4ndle SM, Obermeier B, Senel M, Bruder J, Mentele R, Khademi M, Olsson T, Tumani H, Kristoferitsch W, Lottspeich F et al (2016) Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins. Proc Natl Acad Sci U S A 113:7864\u20137869","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02616-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02616-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:57:01Z","timestamp":1770310621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02616-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2616"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02616-y","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Utah Health Sciences Institutional Review Board approved this study (IRB_47316); all participants signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work supports the University of Utah Disclosure U-6678, Ballard Ref. No.: 21101.0385EP2, patents pending for the \u201cMS Study Panel.\u201d","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Intellectual property"}}],"article-number":"41"}}